Objective: To investigate the prevalence of metabolic syndrome and its associated risk factors in a cohort of university freshmen. Design: A cross-sectional study in a university health center in North Taiwan. Subjects: A total of 8226 students (mean age: 19.272.3 years) receiving pre-entrance health examinations and lifestyle questionnaires during the 2005-2006 academic year were recruited. Measurements: A fasting plasma glucose, lipids, uric acid and hepatitis B serology were measured for each subject. The prevalence of metabolic syndrome and its individual components were examined using the America Heart Association and National Heart Lung Blood Institute criteria. The risk factors for metabolic syndrome were identified using a multivariate logistic regression analysis. Results: The prevalence of overweight, obesity and metabolic syndrome was 12.7% (17.0% in men and 7.6% in women), 13.0% (18.4% in men and 6.4% in women) and 4.6% (6.4% in men and 2.4% in women). The risk for metabolic syndrome increased with an increase of body mass index and plasma uric acid level, and decreased with the vigorous physical activity and current alcohol drinking. Furthermore, as compared to subjects with seroprotective titers from hepatitis B vaccination (antiHBs( þ ) and anti-HBc(À)), those without protective titers of anti-HBs after vaccination or without hepatitis B infection (antiHBs(À) and anti-HBc(À)) had 34% higher risk for metabolic syndrome, and those with natural infection of hepatitis B (anti-HBc( þ )) had 58% higher risk for metabolic syndrome. Conclusions: Overweight, obesity and metabolic syndrome were more common among men than women in university freshmen. Hepatitis B vaccination with anti-HBs( þ ) was associated with a lower risk of metabolic syndrome as compared to antiHBs(À). However, hepatitis B infection presented with anti-HBc( þ ) was associated with a higher risk of metabolic syndrome. The interplay between hepatitis B infection, hepatitis B vaccination and metabolic syndrome needs further investigation.
Introduction
Metabolic syndrome is a constellation of central obesity, impaired glucose metabolism, hypertension and dyslipidemia. Depending on the criteria used, the prevalence of metabolic syndrome in the United States and Europe is around 20-30% in adults, [1] [2] [3] while in Asia, the prevalence is about 10-20%. [3] [4] [5] Recently, Hwang et al. also present the prevalence of metabolic syndrome is 20% in men and 15.3% in women among Taiwanese adults. Metabolic syndrome has been shown to associate with increased risk for all-cause and cardiovascular disease mortality, and also increase the risk for cardiovascular disease and type 2 diabetes in later life. [6] [7] [8] [9] [10] Hence, metabolic syndrome has become one of the major challenges in public health worldwide. It has been well known that obesity is related to the development of metabolic syndrome. 11 The prevalence of obesity has continued to increase significantly in many countries. 12, 13 In addition to increased mortality, obesity has been known to be associated with higher risk of hypertension, diabetes, dyslipidemia and cardiovascular disease as compared to normal counterparts. 14, 15 Since the prevalence of obesity has increased most rapidly among 18-to 29-year-old individuals and those with college education, 16 early intervention can help reducing the morbidity associated with obesity. In addition, the report from the third National Health and Nutrition Examination Survey has demonstrated that the prevalence of metabolic syndrome in American adolescence was 6.8% among overweight subjects and 28.7% among obese individuals. 17 Colleges and universities are therefore important settings for the surveillance, prevention and intervention of obesity and the metabolic syndrome. 18 When students enter colleges at age 18-19 years, this can be a critical period of time when these young adults start forming healthy lifestyles independently and these behaviors may have a significant impact on their health in the future. However, there is little information on obesity and metabolic syndrome among young people. Furthermore, the relationship between the status of hepatitis B immunity and metabolic syndrome remains unclear although chronic hepatitis B infection has been reported to associate with metabolic syndrome. 19 In Taiwan, the universal hepatitis B vaccination program has been initiated for children since 1986. Thus, the goal of our cross-sectional study is to assess the prevalence of overweight, obesity and metabolic syndrome in a cohort of university freshmen in Taiwan. In addition, hepatitis B immunity, plasma uric acid level and lifestyle factors as predictors of metabolic syndrome will also be examined.
Methods

Participants and procedures
The data were collected from the Health Center of National Taiwan University. The American Heart Association and National Heart Lung Blood Institute criteria 22 with a lower waist circumference cutoff (waist circumference: X90 cm in men and X80 cm in women) was used to define the metabolic syndrome, which was based on the presence of three or more of the following components: (1) central obesity (waist circumference: X90 cm in men and X80 cm in women), (2) a high triglycerides (X150 mg per 100 ml (X1.69 mmol l À1 )), a low high-density lipoprotein cholesterol level (o40 mg per 100 ml (o1.036 mmol l
À1
) in men and o50 mg per 100 ml (o1.295 mmol l
) in women), (4) a high blood pressure (systolic X130 mm Hg or diastolic X85 mm Hg), (5) a high fasting plasma glucose (X100 mg per 100 ml (X5.5 mmol l À1 )). Students with known diagnosis of dyslipidemia, hypertension and diabetes or prior medication usages for above conditions were excluded from the study.
Smoking, alcohol drinking and physical activity histories for each subject were obtained from a questionnaire. Current and never smokers were defined as those who reported current use and no use of cigarettes at the time of survey. Current and never alcohol drinkers were defined as those who reported alcohol consumption at least one time per week and less than one time per week. Physical activity was divided into three levels. None/mild physical activity was defined as those who exercised less than 1 h per week. Moderate physical activity was defined as those who exercised between 1 and 4 h per week. Vigorous physical activity was defined as those who exercised more than 4 h per week.
Statistical analysis
Data were expressed as the mean7s.d. for continuous variable unless indicated otherwise. Student's t-test for unpaired data was used for the comparison of mean values between genders. Log transformation was used for variables with significant deviation from normal distribution, assessed by Kolmogorov-Smirnov test before further analyses.
Proportions and categorical variables were tested by the w 2 test. BMI was classified into four groups according to case numbers in quartiles. The plasma uric acid level was also grouped according to gender-specific quartiles. A multiple logistic regression analysis was used to estimate the odds ratios (ORs) of the metabolic syndrome by age, gender, BMI groups, groups of uric acid levels, types of hepatitis B immunity, smoking, alcohol drinking and physical activity histories. The ORs (both crude and adjusted ORs for age, Hepatitis B infection and metabolic syndrome S-L Yen et al gender and BMI) of metabolic syndrome and its individual components were compared between subjects with immunity from hepatitis B virus vaccine and those without. Statistical analysis was performed using SPSS for Windows (version 13.0) on an IBM PC compatible computer.
Results
The anthropometric indices, lifestyle factors and metabolic characteristics were shown in Table 1 . The means of the demographic data except age were statistically different between men and women. The male students had higher prevalence of metabolic syndrome, overweight and obesity than the female students. The prevalence of overweight and obesity was 12.7% (17.0% in men and 7.6% in women) and 13.0% (18.4% in men and 6.4% in women). The prevalence of metabolic syndrome was 4.6% (6.4% in men and 2.4% in women). High blood pressure was the most commonly identified component of metabolic syndrome in men (35.8%), while low high-density lipoprotein cholesterol was the most common in women (43.7%).
Using a multiple logistic regression analysis with metabolic syndrome as the dependent variable, we found that age, gender, BMI quartile, uric acid quartile, hepatitis B immunity, physical activity and alcohol consumption were associated with metabolic syndrome in The prevalence of metabolic syndrome was 3.7% in subjects with anti-HBs( þ ) and anti-HBc(À). Furthermore, among the individual components of metabolic syndrome, subjects with anti-HBs( þ ) and anti-HBc(À) had significantly lower adjusted OR (OR ¼ 0.85, Po0.05) of having high fasting glucose than those with anti-HBs(À) and anti-HBc(À) in Table 3 . However, the titer of anti-HBs was not associated with metabolic syndrome and BMI among subjects with seroprotective titers from hepatitis B vaccination (data not shown).
The prevalence of metabolic syndrome increased with an increment of BMI and serum uric acid level in each gender (tests for trends, Po0.001; Figure 1 ). The prevalence was 0.8% in underweight, 2.1% in normal weight, 4.5% in overweight and 24.2% in obese male subjects, and the corresponding prevalence was 0.3, 0.7, 4.6 and 23.7% in female subjects, respectively. Similarly, the prevalence of metabolic syndrome in each quartile group of uric acid level was 2.5, 4.0, 6.8 and 12.6% in male subjects, and 0.6, 0.8, 2.2 and 6.0% in female subjects, respectively.
Discussion
In this study, we found that overweight, obesity and metabolic syndrome were common in the university freshmen cohort. The male students had higher prevalence of overweight, obesity and metabolic syndrome than the female students. These were comparable to a nationwide cross-sectional survey in Taiwan. 23 The risk for metabolic syndrome was positively associated with an increase of BMI and plasma uric acid levels, and decreased with the vigorous physical activity and current alcohol consumption. Furthermore, we demonstrated, for the first time, that as compared to subjects with seroprotective titers from hepatitis B vaccination, those without protective titers of anti-HBs after vaccination or without hepatitis B infection had 34% higher risk for metabolic syndrome, and those with natural infection of hepatitis B had 58% higher risk for metabolic syndrome.
The pattern of increased prevalence of overweight and obesity increases in western countries can also be observed in Taiwan during the last two decades. 13, [24] [25] [26] However, there is Hepatitis B infection and metabolic syndrome S-L Yen et al little information on obesity among the adolescents in Asia. Compared with college students who have normal weight, overweight students have higher blood pressure, fasting insulin, cholesterol and triglycerides levels. 18 Furthermore, the prevalence of metabolic syndrome in American adolescence is 6.8% among overweight subjects and 28.7% among obese individuals. 17 Similarly, we also found that the OR of having metabolic syndrome was associated with an increment of BMI ( Table 2 ). The prevalence was 4.5% in overweight subjects and 24.1% in obese subjects, respectively ( Figure 1) . Lifestyle factors such as smoking, physical activities and alcohol consumption are associated with the risk of metabolic syndrome in adults. 1, 27, 28 Consistently in the present study, we showed that the ORs of having metabolic syndrome significantly decreased with vigorous physical activity and current alcohol consumption ( Table 2) . However, smoking was nonsignificantly associated with metabolic syndrome. It could be that the current smoking rate was relatively low in these subjects. Plasma uric acid level has been known to associate with metabolic syndrome. For example, the ORs for metabolic syndrome increase with the gender-specific quartiles of uric acid levels after adjusting for age, total cholesterol and smoking status in Japanese adults. 29 In a population-based study, Onat et al. 30 have shown that the OR of metabolic syndrome is 1.89 using the top-versus-bottom tertile of uric acid level adjusting for possible confounders. In addition, uric acid is independently correlated with number of metabolic syndrome components. 31 Similarly, adjusted for age, gender, BMI and other possible confounders, we found that the ORs for metabolic syndrome increased with the increment of gender-specific quartiles of plasma uric acid concentration ( Table 2 ). The OR for metabolic syndrome in the top-versus-bottom quartile of uric acid levels was 3.16 (Po0.001). Hyperuricemia may be a consequence of metabolic syndrome, as insulin resistance decreases the renal excretion of uric acid. 32, 33 Uric acid, however, may play an important role in the pathogenesis of metabolic syndrome, possibly due to its ability to inhibit nitric oxide bioavailability, endothelial function and insulin resistance. [33] [34] [35] Thus, lifestyle intervention together with the judicious selection of drugs for the treatment of metabolic syndrome may result in a reduction of plasma uric acid levels and possibly cardiovascular disease risk. Chronic hepatitis B infection has been reported to associate with decreased risk for metabolic syndrome in a study. 19 Jan et al. 19 have found that, after adjusting for age and gender, those who are HBsAg( þ ) have lower risk (OR ¼ 0.84, Po0.05) for concomitant metabolic syndrome than those who are HBsAg(À). In that study, the criterion to define metabolic syndrome is different and some potential confounders such as BMI and smoking are not adequately adjusted. In contrast, adjusted for age, gender, BMI, smoking and other possible confounders, we showed that subjects with anti-HBc( þ ) had significantly higher risk for metabolic syndrome (OR ¼ 1.58, Po0.05) as compared to subjects with anti-HBs( þ ) and anti-HBs(À) ( Table 2 ). In addition, the risk was not attenuated when the white blood cell count (Po0.001) was added as the independent variable (data not shown). This suggested that inflammation per se could not explain the relationship between hepatitis B infection and metabolic syndrome. Unfortunately, we were not able to analyze the relationship between metabolic syndrome and hepatitis B virus carrier status among those with antiHBc( þ ) because the carrier rate in our cohort was quite low (2.7%). In this issue, further studies are necessary especially in the endemic areas of hepatitis B infection such as Taiwan.
Since the institution of universal hepatitis B vaccination program in 1986, the incidence of hepatocellular carcinoma in children has declined, 36 and the hepatitis B carrier rate has also decreased dramatically in Taiwan. 37, 38 There is no report, however, on the relationship between hepatitis B immunity and metabolic syndrome. Interestingly in this study, we found that subjects with anti-HBs( þ ) and antiHBc(À) had significantly lower OR of metabolic syndrome (OR ¼ 0.77, Po0.05) than those with anti-HBs(À) and antiHBc(À) ( Table 3) . Furthermore, among the individual components of metabolic syndrome, subjects with antiHBs( þ ) and anti-HBc(À) had significantly lower adjusted OR (OR ¼ 0.85, Po0.05) for high fasting glucose than those with anti-HBs(À) and anti-HBc(À). Recently, hepatitis B infection is associated with increased risk of gestational diabetes after adjusting for several confounders. 39 Moreover, hepatitis B infection is positively related to diabetes among Asian Americans. 40 Interestingly, the presence of adenovirus Ad-36 antibodies is associated with increased body weight in humans. 41 In addition, Ad-36 is found to modulate adipocyte differentiation, leptin production and glucose metabolism. 42 Similarly, the role of hepatitis B infection and serology status in human metabolism deserves further investigation. In summary, we found that overweight, obesity and metabolic syndrome were more common among male than female subjects in a cohort of university freshmen. The risk for metabolic syndrome increased with an increase in BMI and plasma uric acid levels, and decreased with the vigorous physical activity and current alcohol drinking. Hepatitis B vaccination with anti-HBs( þ ) was associated with a lower risk of metabolic syndrome as compared to anti-HBs(À). However, hepatitis B infection presented with anti-HBc( þ ) was associated with a higher risk of metabolic syndrome. Although our study is limited by the cross-sectional design and does not answer the causal relationship between the status of hepatitis B immunity and metabolic syndrome, the interplay between hepatitis B infection, hepatitis B vaccination and metabolic syndrome needs further investigation. Furthermore, a prospective study is warranted to determine whether hepatitis B vaccination can protect high-risk individuals from developing metabolic disorders.
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